MON-406 Two Cases of Aggressive Corticotroph Pituitary Tumors Treated with Capecitabine and Temozolomide

Introduction: Aggressive corticotroph tumors exhibit continued growth despite multimodal therapy, including surgeries, radiotherapy and/or medical treatment. Temozolomide (TMZ), an oral alkylating agent, has been used to treat aggressive pituitary tumors; however, most patients only showed a partial...

Descripción completa

Detalles Bibliográficos
Autores principales: Tateno, Tae, Tateno, Toru, Chik, Constance
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550942/
http://dx.doi.org/10.1210/js.2019-MON-406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550942/
http://dx.doi.org/10.1210/js.2019-MON-406

Ejemplares similares